Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Abstract Text:

E Mark Haacke,Muhammad Ayaz,Asadullah Khan,Elena S Manova,Bharani Krishnamurthy,Lakshman Gollapalli,Carlo Ciulla,I Kim,Floyd Petersen,Wolff Kirsch,

PURPOSE: To establish a baseline of phase differences between tissues in a number of regions of the human brain as a means of detecting iron abnormalities using magnetic resonance imaging (MRI). MATERIALS AND METHODS: A fully flow-compensated, three-dimensional (3D), high-resolution, gradient-echo (GRE) susceptibility-weighted imaging (SWI) sequence was used to collect magnitude and phase data at 1.5 T. The phase images were high-pass-filtered and processed region by region with hand-drawn areas. The regions evaluated included the motor cortex (MC), putamen (PUT), globus pallidus (GP), caudate nucleus (CN), substantia nigra (SN), and red nucleus (RN). A total of 75 subjects, ranging in age from 55 to 89 years, were analyzed. RESULTS: The phase was found to have a Gaussian-like distribution with a standard deviation (SD) of 0.046 radians on a pixel-by-pixel basis. Most regions of interest (ROIs) contained at least 100 pixels, giving a standard error of the mean (SEM) of 0.0046 radians or less. In the MC, phase differences were found to be roughly 0.273 radians between CSF and gray matter (GM), and 0.083 radians between CSF and white matter (WM). The difference between CSF and the GP was 0.201 radians, and between CSF and the CN (head) it was 0.213 radians. For CSF and the PUT (the lower outer part) the difference was 0.449 radians, and between CSF and the RN (third slice vascularized region) it was 0.353 radians. Finally, the phase difference between CSF and SN was 0.345 radians. CONCLUSION: The Gaussian-like distributions in phase make it possible to predict deviations from normal phase behavior for tissues in the brain. Using phase as an iron marker may be useful for studying absorption of iron in diseases such as Parkinson's, Huntington's, neurodegeneration with brain iron accumulation (NBIA), Alzheimer's, and multiple sclerosis (MS), and other iron-related diseases. The phases quoted here will serve as a baseline for future studies that look for changes in iron content.

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Publishing Authors By Initials

EM Haacke,M Ayaz,A Khan,ES Manova,B Krishnamurthy,L Gollapalli,C Ciulla,I Kim,F Petersen,W Kirsch,

For similar natural sciences: weights and measures: reference standards research abstracts see: natural sciences: weights and measures: reference standards research

PUBMED ID PMID:

MEDLINE DATE:

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of magnetic resonance imaging : JMRI

VOLUME: 26

Page Numbers: 256-64

Journal Abbreviation:

ISSN: 1053-1807

DAY: 3

MONTH: Aug

YEAR: 2007

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9105850

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Keywords Mesh Terms:

KEYWORDS: Reference Standards

MESH TERMS: methods

Chemical & Substance for Abstract: Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. Information

Substance Name: Iron

Registry Number: 7439-89-6

Grant and Affiliation Information for Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.

AFFILIATION: MRI Institute for Biomedical Research, Detroit, Michigan, USA. nmrimaging@aol.com

Country: United States

AGENCY: United States NIA

GRANT: AG20948

ACRONYM: AG

MEDLINETA: J Magn Reson Imaging

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs abnormal iron content in the brain Related Publications

• 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
• Annexin V/beta5 integrin interactions regulate apoptosis of growth plate chondrocytes.
• Cofactor-directed reversible denaturation pathways: the cofactor-stabilized Escherichia coli aspartate aminotransferase homodimer unfolds through a pathway that differs from that of the apoenzyme.
• Development of a neuroprosthesis for restoring arm and hand function via functional electrical stimulation following high cervical spinal cord injury.
• Duty hours restriction and their effect on resident education and academic departments: the American perspective.
• EMG-based Control for a C5/C6 Spinal Cord Injury Upper Extremity Neuroprosthesis.
• Effects of spinal cord injury on lower-limb passive joint moments revealed through a nonlinear viscoelastic model.
• Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain.
• Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence.
• Identification of functional paralog shift mutations: conversion of Escherichia coli malate dehydrogenase to a lactate dehydrogenase.
• Immunophenotypes in the circulation of patients with mild cognitive impairment.
• Increased production of inflammatory cytokines in mild cognitive impairment.
• Influence of vigilance and learning on prefrontal activation in schizophrenia.
• Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias.
• Iterative approach to polyketide-type structures: stereoselective synthesis of 1,3-polyols utilizing the catalytic asymmetric Overman esterification.
• Keeping Pace With GI Technology: Knowing When to Get Out.
• Mechanisms of seizure propagation in a cortical model.
• N-nitroso-melatonin releases nitric oxide in the presence of serotonin and its derivatives.
• Oral cavity cancer.
• Percutaneous multilevel decompressive laminectomy, foraminotomy, and instrumented fusion for cervical spondylotic radiculopathy and myelopathy: assessment of feasibility and surgical technique.
• Perioperative care of patients with neuromuscular disease and dysfunction.
• Preliminary demonstration of an allelic association of the IREB2 gene with Alzheimer's disease.
• Randomized comparison of phone versus in-person BRCA1/2 predisposition genetic test result disclosure counseling.
• Recombinant expression of twelve evolutionarily diverse subfamily Ialpha aminotransferases.
• Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain.
• Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2.
• Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation.
• Sutureless circumcision using 2-octyl cyanoacrylate (Dermabond): appraisal after 18-month experience.
• The unfolding pathway for Apo Escherichia coli aspartate aminotransferase is dependent on the choice of denaturant.
• [Not Available.]